According to Morgan Keegan, MedAssets MDAS saw a strong quarter.
Morgan Keegan said that MDAS reported June results of $0.23 on $147.9 million versus consensus of $0.16 on $145.5 million. “We believe the cash flow enhancing software/services that MDAS provides will be in high demand as hospitals face reimbursement pressure and expect organic growth to accelerate materially in 2012. Maintain an Outperform on these shares at 12x our 2011 estimate versus the group at 36x.”
MedAssets closed yesterday at $12.00.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in